SAB Biotherapeutics (SABS.BOATS) Q2 2026 Earnings

May 12Confirmed
Q4 2025
Q2 2026
-0.46
-0.38
-0.29
-0.21

Details

Expected EPS
-0.212475
Actual EPS
-0.35
Surprise EPS
-0.14
Surprise Percent
-64.73%

Description

⁨SAB Biotherapeutics⁩ (⁦SABS.BOATS⁩) has reported earnings of ⁦-0.35⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts